[Ac 225]RTX-2358
/ Ratio Therap
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
November 27, 2025
ATLAS: Actinium Therapy for Late-stage Aggressive Sarcomas
(clinicaltrials.gov)
- P1 | N=26 | Recruiting | Sponsor: Ratio Therapeutics, Inc. | Not yet recruiting ➔ Recruiting
Enrollment open • Oncology • Sarcoma • Soft Tissue Sarcoma • Solid Tumor
November 23, 2025
A PH/2 STUDY OF THE RADIOPHARMACEUTICAL [AC-225]RTX-2358 IN THE TREATMENT OF RELAPSED / REFRACTORY (R/R) SOFT TISSUE SARCOMA (STS) THE ATLAS STUDY - ACTINIUM THERAPY FOR LATE-STAGE AGGRESSIVE SARCOMAS
(CTOS 2025)
- "N/A"
Oncology • Sarcoma • Soft Tissue Sarcoma • Solid Tumor • CAFs • FAP
1 to 2
Of
2
Go to page
1